Loading...

215 posters, 5 topics, 22 sessions, 596 authors, 283 institutions

ePostersLive by SciGen Technologies S.A. All rights reserved.

Obstetric Anaesthesia Annual Scientific Meeting 2025

May 15 - 16, 2025 | ICC, 2 Lanyon Place, Belfast BT1 3WH

Obstetric Anaesthesia Annual Scientific Meeting 2025 banner

6711774

Perioperative opioid use for airway management in Obstetrics

Part of Topic

Quality Improvement

PERIOPERATIVE OPIOID USE FOR AIRWAY MANAGEMENT IN OBSTETRICS

Introduction:

There is a hesitation to use opioids in obstetric airway management due to the fear of neonatal respiratory depression. Opioids are the effective agents to suppress the pressor response to laryngoscopy. Many cases of intracranial bleeding were reported during LSCS under general anesthesia

Methodology:

The aim of the audit was

1. To observe the trend of opioid use in our maternity unit

2. APGAR scores of babies – in view of standardizing opioid use

Phase 1: retrospective audit of one year (2023) – opioid type, dose, timing & APGAR

Phase 2: Survey of anesthetists using online questionnaire

 

 

The mean APGAR score at 1 and 5 mins 6.25 and 8.40 who received opioids and 6.88 and 8.66 in whom did not receive any opioids for induction, respectively.

There was no statistical difference (p 0.312) in APGAR scores between those who received and not received opioids.

72.2 % of anesthetists think opioid administration causing low APGAR scores as the reason for hesitation in airway management in obstetrics.

Remifentanil was used in two cases of Arnold-Chiari malformations.

 

CONCLUSION:  More change in attitude and practice for more opioid use for managing airways in obstetrics & More research  to define the ideal dose and timing of opioid administration during general anesthesia for caesarean sections

oaa2025 banner
Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.